脑肿瘤诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按诊断类型(成像测试、活检、分子测试和其他)、肿瘤类型、最终用户和地理划分

市场快照

Brain Tumor Diagnostics Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.3 %
Brain Tumor Diagnostics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,研究的脑肿瘤诊断市场预计将以 3.3% 的复合年增长率增长。促成市场增长的重要因素是脑癌发病率的上升和诊断设备的技术进步。全球日益增长的老年人口也推动了脑肿瘤诊断市场的发展。根据美国癌症协会的数据,2019 年确诊的原发性脑肿瘤新病例超过 79,000 例,其中约 1%(约 23,880 例)为恶性。诊断的中位年龄为 59 岁,但最常见于儿童和老年人。暴露于电离辐射,无论是医疗(疾病治疗)还是原子弹暴露,都与某些形式的主要脑肿瘤的发生有关,包括神经胶质瘤、脑膜瘤和肉瘤,特别是当暴露发生在儿童时期时。所有这些因素都有望在预测期内促进脑肿瘤诊断市场的增长。

报告范围

脑瘤是由大脑中癌细胞的异常生长引起的。在全球范围内,脑肿瘤是导致死亡的主要原因之一。各种诊断技术用于脑肿瘤的诊断,例如 MRI、活组织检查等。

By Diagnostic Type
Imaging Test
MRI
CT Scan
Other
Lumbar Puncture
Biopsy
Molecular Testing
Others
By Tumor Type
Metastatic
Meningioma
Glioblastoma
Pituitary Endoma
Others
By End User
Hospitals
Diagnostics Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

MRI 细分市场有望在脑肿瘤诊断市场中占有最大的市场份额

  • 由于在脑肿瘤诊断中的高度应用等属性,MRI部分保留了主导份额。预计全球脑癌病例发病率的上升将推动预测期内对脑肿瘤诊断市场的需求。根据美国中央脑肿瘤登记处 2018 年报告,预计 2019 年美国将新增 86,970 例原发性恶性和非恶性脑肿瘤和其他中枢神经系统肿瘤病例。估计有 26,170 例原发性恶性肿瘤预计 2019 年美国将诊断出 60,800 种非恶性疾病。
  • 此外,扫描技术的发展推动了发展,例如开放式 MRI 设备、软件和超导磁体的发展。造影剂(如钆-DTPA)的进展,顺磁性造影剂被用作静脉注射剂,可在 20 分钟至 1 小时内提供清晰、可靠和精确的图像。
Brain Tumor Diagnostics Market Share

北美在市场上占主导地位,预计在预测期内也会如此

预计北美将在整个预测期内保持其在整个脑肿瘤诊断市场的主导地位。这是由于脑癌患病率上升和老年人口不断增长等因素造成的。在美国,2018 年所有原发性恶性和非恶性脑及其他中枢神经系统肿瘤的发病率为每 100,000 例 23.03 例,肿瘤发病总数为 392,982 例。此外,完善的医疗保健基础设施,加上该地区民众对先进技术的认识不断提高,以及对成熟诊断方法的强烈接受,也是确保该地区主导地位的一些关键因素。

Brain Tumor Diagnostics Market Growth

竞争格局

脑肿瘤诊断市场竞争激烈,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。一些知名企业正在积极与其他公司进行合作、收购和推出新产品,以巩固其在全球的市场地位。目前主导市场的一些公司包括 GE Healthcare、Koninklijke Philips NV、Siemens Healthcare GmbH、Fujifilm Corporation 和 Hitachi, Ltd。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Neurological Disorders and Cancers

      2. 4.2.2 Rising Number of Smokers

    3. 4.3 Market Restraints

      1. 4.3.1 Heavy costs associated with diagnosis

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Diagnostic Type

      1. 5.1.1 Imaging Test

        1. 5.1.1.1 MRI

        2. 5.1.1.2 CT Scan

        3. 5.1.1.3 Other

      2. 5.1.2 Lumbar Puncture

      3. 5.1.3 Biopsy

      4. 5.1.4 Molecular Testing

      5. 5.1.5 Others

    2. 5.2 By Tumor Type

      1. 5.2.1 Metastatic

      2. 5.2.2 Meningioma

      3. 5.2.3 Glioblastoma

      4. 5.2.4 Pituitary Endoma

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Diagnostics Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Koninklijke Philips N.V.

      3. 6.1.3 Siemens Healthcare GmbH

      4. 6.1.4 Fujifilm Corporation

      5. 6.1.5 Hitachi, Ltd.

      6. 6.1.6 Hologic, Inc.

      7. 6.1.7 NantOmics

      8. 6.1.8 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Brain Tumor Diagnostics Market market is studied from 2018 - 2026.

The Brain Tumor Diagnostics Market is growing at a CAGR of 3.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Fujifilm Corporation, Hitachi, Ltd. are the major companies operating in Brain Tumor Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!